Medications to reduce cardiovascular risk after kidney transplantation

Transplantation. 2011 Mar 15;91(5):492-3. doi: 10.1097/TP.0b013e318208c885.
No abstract available

Publication types

  • Comment

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Kidney Transplantation*
  • Postoperative Complications
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors